UNKNOWN VICRYL RAPIDE SUTURE
Report
- Report Number
- 2210968-2024-03587
- Event Type
- Injury
- Date Received
- March 28, 2024
- Date of Event
- July 29, 2022
- Report Date
- March 28, 2024
- Manufacturer
- ETHICON INC.
- Product Code
- GAM
- PMA / PMN Number
- K033746
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- US
- Reporter Occupation
- OTHER
Narratives
PRODUCT COMPLAINT #: (B)(4). THIS REPORT IS BEING SUBMITTED PURSUANT TO THE PROVISIONS OF 21 CFR, PART 803. THIS REPORT MAY BE BASED ON INFORMATION WHICH HAS NOT BEEN INVESTIGATED OR VERIFIED PRIOR TO THE REQUIRED REPORTING DATE. THIS REPORT DOES NOT REFLECT A CONCLUSION BY ETHICON INC, OR ITS EMPLOYEES THAT THE REPORT CONSTITUTES AN ADMISSION THAT THE PRODUCT, ETHICON INC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE POTENTIAL EVENT DESCRIBED IN THIS REPORT. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL REPORT, A FOLLOW-UP REPORT WILL BE FILED AS APPROPRIATE. ATTEMPTS ARE BEING MADE TO OBTAIN THE FOLLOWING INFORMATION. TO DATE NO RESPONSE HAS BEEN PROVIDED. IF FURTHER DETAILS ARE RECEIVED AT A LATER DATE A SUPPLEMENTAL MEDWATCH WILL BE SENT. DOES THE SURGEON BELIEVE THAT ANY OF THE ETHICON PRODUCTS INVOLVED CAUSED AND/OR CONTRIBUTED TO THE POST-OPERATIVE COMPLICATIONS DESCRIBED IN THE ARTICLE? WHICH SPECIFIC ETHICON PRODUCTS HAVE BEEN USED DURING THE PROCEDURES (PRODUCT CODE, LOT NUMBER)? DOES THE SURGEON BELIEVE THERE WAS ANY DEFICIENCY WITH ANY OF THE ETHICON PRODUCTS USED IN THIS PROCEDURE? IF SO, PLEASE PROVIDE DETAILS. WERE THE CASES DISCUSSED IN THIS ARTICLE PREVIOUSLY REPORTED TO ETHICON? IF YES, PLEASE PROVIDE A COMPLAINT REFERENCE NUMBER. PATIENT DEMOGRAPHICS? THIS REPORT IS RELATED TO A JOURNAL ARTICLE; THEREFORE, NO PRODUCT WILL BE RETURNED FOR ANALYSIS AND THE BATCH HISTORY RECORDS CANNOT BE REVIEWED AS THE LOT NUMBER HAS NOT BEEN PROVIDED. H6 COMPONENT CODE: G07002 ¿ DEVICE NOT RETURNED. RELATED EVENTS CAPTURED VIA 2210968-2024-03586. CITATION: SURGICAL NEUROLOGY INTERNATIONAL ¿ 2022 ¿ 13(328) / HTTPS://DOI.ORG/10.25259/SNI_329_2022.
TITLE: IMPAIRED WOUND HEALING FOLLOWING CRANIAL VAULT RECONSTRUCTION IN A PATIENT WITH AN ATYPICAL PHENOTYPE OF MARFAN SYNDROME: A CASE REPORT: A 7-MONTH-OLD FEMALE PATIENT WITH MFS AND METOPIC CRANIOSYNOSTOSIS WITH AN UNUSUAL CLINICAL PRESENTATION WHO UNDERWENT CRANIAL VAULT RECONSTRUCTION WITH FRONTO-ORBITAL ADVANCEMENT AND ANTERIOR CRANIAL VAULT REMODELING. AT 4 WEEK FOLLOW-UP, THE PATIENT WAS NOTED TO HAVE A SMALL AREA OF DEHISCENCE AT THE RIGHT SCALP INCISION. THERE WAS NO ACTIVE INFECTION AND WOUND CARE WAS STRESSED TO THE PATIENT¿S PARENTS IN HOPES OF SECONDARY WOUND HEALING. THE PATIENT PRESENTED 1 MONTH LATER FOR FOLLOW-UP AND WAS NOTED TO HAVE A 2 CM × 2 CM AREA OF ULCERATED SKIN AT THE LATERAL ASPECT OF THE RIGHT SCALP FLAP. AGAIN, THIS DID NOT APPEAR TO BE ACTIVELY INFECTED, BUT WAS FAILING TO HEAL. THE PATIENT WAS TAKEN TO THE OPERATING ROOM FOR WOUND DEBRIDEMENT AND SCALP CLOSURE, AFTER WHICH THE WOUND HEALED WELL WITHOUT FURTHER COMPLICATION. THE GALEA AND DERMIS WERE CLOSED WITH 3-0 COATED POLYGLACTIN 910 BRAIDED ABSORBABLE SUTURE (VICRYL, ETHICON, INC., JOHNSON AND JOHNSON CO, RARITAN, NJ). DURING CLOSURE, THE GALEA AND DERMIS TOLERATED ONLY MINIMAL TENSION BEFORE STITCHES WOULD PULL-THROUGH. THE DERMIS APPEARED ATROPHIC TO ALMOST NONEXISTENT. SKIN WAS CLOSED WITH 4-0 VICRYL RAPIDE¿ SUTURE (ETHICON, INC., JOHNSON AND JOHNSON CO, RARITAN, NJ) IN A RUNNING FASHION. REPORTED COMPLICATIONS INCLUDED WOUND DEHISCENCE AT THE RIGHT SCALP INCISION (N=1) AND ULCERATED SKIN (N=1). IN CONCLUSION, PHENOTYPIC OVERLAP BETWEEN GENETIC DISORDERS CAN CONFOUND CLINICAL DIAGNOSIS AS ILLUSTRATED IN THIS CASE. GENETIC TESTING CAN BE HIGHLY VALUABLE IN THE DIAGNOSIS OF CLINICALLY VARIABLE DISORDERS. PATIENTS WITH MFS WHO UNDERGO CRANIAL SURGERY MAY BE AT INCREASED RISK FOR WOUND HEALING COMPLICATIONS.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1028027 | UNKNOWN VICRYL RAPIDE SUTURE | SUTURE, ABSORBABLE, SYNTHETIC | GAM | ETHICON INC. |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Unknown | Required Intervention |